A randomized study assessing the effect of diet in cats with hypertrophic cardiomyopathy

L M Freeman1, J E Rush, S M Cunningham

  • 1Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA.

Insights

Dietary changes may impact hypertrophic cardiomyopathy (HCM) in cats. Specific diets altered biochemical markers and cardiac measurements, suggesting a role for nutrition in managing feline HCM.

Area of Science:

  • Veterinary Cardiology
  • Animal Nutrition
  • Biochemistry

Background:

  • Dietary interventions are explored for their potential to influence the progression of hypertrophic cardiomyopathy (HCM).
  • Hypertrophic cardiomyopathy is a significant cardiac condition in feline patients.

Purpose of the Study:

  • To investigate the effects of different diet compositions on clinical, biochemical, and echocardiographic parameters in cats diagnosed with HCM.
  • To determine if specific nutritional strategies can alter disease markers in feline hypertrophic cardiomyopathy.

Main Methods:

  • A randomized, placebo-controlled trial involving 29 cats with International Small Animal Cardiac Health Council stage 1b HCM.
  • Cats were assigned to one of three diets varying in macronutrient content and ingredients, with measurements repeated after a six-month period.

Main Results:

  • No significant changes were observed in primary echocardiographic endpoints (left ventricular free wall and interventricular septal thickness) across all groups.
  • One diet group showed increases in blood urea nitrogen (BUN) and cholesterol, while another exhibited increased BUN, cholesterol, triglycerides, and decreased NT-proBNP and hs-troponin I.
  • A third diet group demonstrated decreased body weight, left atrial dimension, interventricular septal thickness in systole, and liver enzymes.

Conclusions:

  • The study suggests that diet composition may influence certain clinical, biochemical, and echocardiographic variables in cats suffering from HCM.
  • Nutritional management could play a role in modulating specific health markers in feline hypertrophic cardiomyopathy, although primary cardiac structural changes were not significantly altered.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790